Dr. Reddy’s Laboratories Ltd ADR (RDY)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$12.39B
EV to revenue ratio (TTM)
3.49
EV to ebitda
18.82
Financial Performance
Revenue (TTM)
$329.84B
Gross profit (TTM)
$163.24B
EBITDA
$49.79B
Profitability
Operating margin (TTM)
14.70%
Profit margin
8.49%
Return on assets (TTM)
3.37%
Return on equity (TTM)
7.34%
Per Share Metrics
Revenue per share (TTM)
$66.15
EPS
$0.36
Diluted EPS (TTM)
$0.36
Book value
$0.82
Dividend per share
$8
Dividend yield
0.56%
Valuation Multiples
P/E ratio
41.28
Trailing P/E
41.28
Forward P/E
32.36
PEG ratio
2.06
Price to sales ratio (TTM)
0.04
Price to book ratio (TTM)
3.06
Growth
Quarterly earnings growth (YoY)
-1.50%
Quarterly revenue growth (YoY)
-35.70%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
2
Sell
1
Strong sell
0
Risk & Volatility
Beta
0.20